MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 3 analysts with an average price target of $138.67. This is a potential upside of $109.59 (376.86%) from yesterday's end of day stock price of $29.08.

Mersana Therapeutics's activity chart (see below) currently has 39 price targets and 39 ratings on display. The stock rating distribution of MRSN is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.47% with an average time for these price targets to be met of 331.17 days.

Highest price target for MRSN is $30.75, Lowest price target is $30, average price target is $30.38.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 13-Nov-2025. First documented stock forecast 24-Jul-2017.

Currently out of the existing stock ratings of MRSN, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 13-Nov-2025

$30.75

$1.71 (5.89%)

$36

1 months 26 days ago
(13-Nov-2025)

0/4 (0%)

$3.32 (12.10%)

Buy

Since 24-Jul-2017

$30

$0.96 (3.31%)

4 months 25 days ago
(14-Aug-2025)

1/4 (25%)

$22.58 (304.31%)

1072

Buy

Since 29-Feb-2024

$175

8 months 2 days ago
(06-May-2025)

2/3 (66.67%)

$39 (28.68%)

66

1 years 10 months 10 days ago
(29-Feb-2024)

0/2 (0%)

$10.19 (175.39%)

Hold

Since 28-Jul-2023

$25

$-4.04 (-13.91%)

$375

2 years 5 months 11 days ago
(28-Jul-2023)

1/2 (50%)

$-6.5 (-20.63%)

532

Show more analysts

Please expand the browser size to see the chart

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 331.17 days on average for the stock forecasts to be realized with a an average price target met ratio 43.47

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

DEBJIT CHATTOPADHYAY

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Debjit Chattopadhyay works at GUGGENHEIM and has 3 price targets and 3 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Debjit Chattopadhyay with highest potential upside - $620.96

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

Ashik Kurian with lowest potential downside - -$4.04

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?